DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Accrued Liabilities

3 Months Ended

Mar. 31, 2019

9.	Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	March 31, 2019		December 31, 2018
Accrued compensation	$	365	$	417
Accrued clinical study costs		255		292
Accrued research and other professional fees		33		65
Accrued taxes and other liabilities		33		34
Total accrued liabilities	$	686	$	808